22 /100
LOW RISK
Score updated May 30, 2026

TAK — Takeda Pharmaceutical Company Limited Dilution Risk Tracker

Track TAK dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TAK — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for TAK.
🔔 Track TAK — Get forecast alerts →

💹 Market Data

Market Cap$50.43B
Shares Outstanding3.16B
Float1.58B
Cash$3.74B
Debt$34.24B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 1.3% shares (2025Q4 vs prior)
174 institutional holders · 63.40M shares
#1 Frazier Life Sciences Management, L.P. 12.47M shares
#2 Medicxi Ventures Management (Jersey) Ltd 7.46M shares
#3 Invesco Ltd. 3.92M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.88M
Days to Cover1.1
% of Float0.2%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track TAK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TAK — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for TAK
📊 TAK FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 TAK Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.